Approval · Notice of Compliance 5515 · 1994
ELDEPRYL: Notice of Compliance 5515
Issued August 12, 1994
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5515
- Date
- August 12, 1994
- Company
- Draxis Health Inc.Mississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Antiparkinsonian agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ELDEPRYL | 02123312 | Cancelled Post Market |
Medicinal ingredients
- SELEGILINE HYDROCHLORIDE 5 MG per TAB